What type of therapy is prescribed to children aged 5-11 experiencing intermittent asthma symptoms?

Short-acting beta agonists (SABAs) are commonly used as rescue medications for the immediate relief of asthma symptoms in children aged 5-11 who experience intermittent asthma. These medications work quickly to relax the muscles around the airways, facilitating easier breathing during an asthma attack or when symptoms flare. SABAs are indicated for the treatment of intermittent asthma because they can effectively alleviate acute symptoms and provide prompt relief.

For children with intermittent asthma, regular use of a long-term control medication like an inhaled corticosteroid (ICS) is generally not necessary, as their symptoms are not frequent enough to warrant ongoing treatment. Montelukast is also primarily used for longer-term management of asthma rather than for immediate symptom relief. Long-acting beta agonists (LABAs) are not recommended as a standalone therapy for asthma in children; they should only be used in combination with ICS due to safety considerations. Therefore, SABAs are recognized as the appropriate choice for managing intermittent asthma symptoms in this age group.